Idiopathic Pulmonary Fibrosis

Subscribe to Idiopathic Pulmonary Fibrosis feed
idiopathic pulmonary fibrosis: Latest results from PubMed
URL: https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1BwDT-LAhNxDxeoUykcB6fqS3vr8vltIMyn_xZRo_8slnlG1tn&utm_medium=rss&utm_source=Other&ff=20250425095108&v=2.18.0.post9+e462414&utm_content=1BwDT-LAhNxDxeoUykcB6fqS3vr8vltIMyn_xZRo_8slnlG1tn
Updated: 2 hours 10 min ago

Pirfenidone

Sun, 2012-01-01 06:00

2025 Apr 15. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–.

ABSTRACT

Pirfenidone is an orally available pyridinone derivative that inhibits collagen formation and is used to treat idiopathic pulmonary fibrosis. Elevations in serum enzyme levels during pirfenidone therapy are not uncommon, but it has yet to be implicated in cases of clinically apparent liver injury with jaundice.

PMID:31644078 | Bookshelf:NBK548769

Categories: Literature Watch

Pages